OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fitness and frailty in myeloma
Charlotte Pawlyn, Abdullah Khan, Ciara L. Freeman
Hematology (2022) Vol. 2022, Iss. 1, pp. 337-348
Open Access | Times Cited: 11
Charlotte Pawlyn, Abdullah Khan, Ciara L. Freeman
Hematology (2022) Vol. 2022, Iss. 1, pp. 337-348
Open Access | Times Cited: 11
Showing 11 citing articles:
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy
Matthew Rees, Shaji Kumar
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1560-1575
Closed Access | Times Cited: 12
Matthew Rees, Shaji Kumar
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1560-1575
Closed Access | Times Cited: 12
Management of Multiple Myeloma: A Review for General Practitioners in Oncology
Bethany Monteith, Irwindeep Sandhu, Ann Lee
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4382-4401
Open Access | Times Cited: 15
Bethany Monteith, Irwindeep Sandhu, Ann Lee
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4382-4401
Open Access | Times Cited: 15
Perspectives on the Treatment of Multiple Myeloma
Abdul Rafae, Frits van Rhee, Samer Al Hadidi
The Oncologist (2023) Vol. 29, Iss. 3, pp. 200-212
Open Access | Times Cited: 15
Abdul Rafae, Frits van Rhee, Samer Al Hadidi
The Oncologist (2023) Vol. 29, Iss. 3, pp. 200-212
Open Access | Times Cited: 15
The Management of older patients with Hodgkin lymphoma: implications of S1826
Marshall McKenna, Yun Kyoung Tiger, Sarah C. Rutherford, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 236-244
Open Access | Times Cited: 4
Marshall McKenna, Yun Kyoung Tiger, Sarah C. Rutherford, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 236-244
Open Access | Times Cited: 4
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients
Massimo Bilancia, Antonio Giovanni Solimando, Fabio Manca, et al.
Computational Statistics & Data Analysis (2025), pp. 108130-108130
Closed Access
Massimo Bilancia, Antonio Giovanni Solimando, Fabio Manca, et al.
Computational Statistics & Data Analysis (2025), pp. 108130-108130
Closed Access
Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
Marc S. Raab, Elena Zamagni, Salomon Manier, et al.
eJHaem (2023) Vol. 4, Iss. 4, pp. 1117-1131
Open Access | Times Cited: 5
Marc S. Raab, Elena Zamagni, Salomon Manier, et al.
eJHaem (2023) Vol. 4, Iss. 4, pp. 1117-1131
Open Access | Times Cited: 5
The Haemato‐Oncology Frailty (HOF ) score to assess frailty in lymphoma
Hena Ramdany, Thomas Lofaro, Simona Deplano
European Journal Of Haematology (2023) Vol. 112, Iss. 4, pp. 611-620
Closed Access | Times Cited: 3
Hena Ramdany, Thomas Lofaro, Simona Deplano
European Journal Of Haematology (2023) Vol. 112, Iss. 4, pp. 611-620
Closed Access | Times Cited: 3
Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications
Katja Schoeller, Gabriele Ihorst, Heike Reinhardt, et al.
Haematologica (2023)
Open Access | Times Cited: 2
Katja Schoeller, Gabriele Ihorst, Heike Reinhardt, et al.
Haematologica (2023)
Open Access | Times Cited: 2
Racial disparities in multiple myeloma and access to stem cell transplantation
Joselle Cook
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Joselle Cook
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
What is the ideal approach—doublet, triplet, or quadruplet(s)?
Shaji Kumar
Hematology (2024) Vol. 2024, Iss. 1, pp. 551-560
Closed Access
Shaji Kumar
Hematology (2024) Vol. 2024, Iss. 1, pp. 551-560
Closed Access
Advances in the management of myeloma: an update
Teresa Meenaghan, Amjad Hayat, Geraldine Walpole, et al.
British Journal of Nursing (2023) Vol. 32, Iss. 17, pp. S4-S12
Closed Access | Times Cited: 1
Teresa Meenaghan, Amjad Hayat, Geraldine Walpole, et al.
British Journal of Nursing (2023) Vol. 32, Iss. 17, pp. S4-S12
Closed Access | Times Cited: 1
